BackIDEX Biometrics ASA Overview

IDEX Biometrics ASA EBIT

IDEX Biometrics ASA's EBIT is $-14M, below the Technology sector average of $14T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$2.00M
129.33% YoY

As of Sep 30, 2024

Annual EBIT (TTM)

-$13.81M
51.28% YoY

Trailing 12 months ending Sep 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

IDEX Biometrics ASA (IDBA) FAQ

The latest EBIT for IDBA is $-14M as of September 2024. That compares with $-28M in the prior-year period — up 51.3% year over year. That is below the Technology sector average of $14T. Investors often review this figure alongside IDEX Biometrics ASA's historical trend and sector peers before judging valuation or financial health.

Over the past year, IDBA's EBIT moved from $-28M to $-14M — a 51.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in IDEX Biometrics ASA's operating scale or balance-sheet position.

Against Technology companies, IDBA currently prints $-14M for EBIT, while the sector average sits near $14T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at IDEX Biometrics ASA's growth, margins, and balance sheet.

A EBIT figure of $-14M for IDBA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $14T. Explore the charts below for those layers of context.

After noting IDBA's EBIT ($-14M), review year-over-year change from $-28M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.